Prognostic indicators in venous ulcersPHILLIPS, Tania J; MACHADO, Fidelis; TROUT, Richard et al.Journal of the American Academy of Dermatology. 2000, Vol 43, Num 4, pp 627-630, issn 0190-9622Article

Kinetic analysis by HPLC-electrospray mass spectrometry of the pH-dependent acyl migration and solvolysis as the decomposition pathways of ifetroban 1-O-acyl glucuronideKHAN, S; TEITZ, D. S; JEMAL, M et al.Analytical chemistry (Washington, DC). 1998, Vol 70, Num 8, pp 1622-1628, issn 0003-2700Article

Disposition of radiolabeled ifetroban in rats, dogs, monkeys, and humansDOCKENS, R. C; SANTONE, K. S; MITROKA, J. G et al.Drug metabolism and disposition. 2000, Vol 28, Num 8, pp 973-980, issn 0090-9556Article

Effects of isoprostane on tubuloglomerular feedback: roles of TP receptors, NOS, and salt intakeWELCH, William J.American journal of physiology. Renal physiology. 2005, Vol 57, Num 4, pp F757-F762, issn 1931-857XArticle

Effect of aspirin and ifetroban on skeletal muscle blood flow in patients with congestive heart failure treated with enalaprilKATZ, S. D; RADIN, M; GRAVES, T et al.Journal of the American College of Cardiology. 1999, Vol 34, Num 1, pp 170-176, issn 0735-1097Article

Inhibition of prostaglandin D₂ clearance in rat hepatocytes by the thromboxane receptor antagonists daltroban and ifetroban and the thromboxane synthase inhibitor furegrelatePESTEL, Sabine; NATH, Annegret; JUNGERMANN, Kurt et al.Biochemical pharmacology. 2003, Vol 66, Num 4, pp 643-652, issn 0006-2952, 10 p.Article

Ifetroban sodium : An effective TxA₂/PGH₂ receptor antagonistROSENFELD, Louis; GROVER, Gary J; STIER, Charles T et al.Cardiovascular drug reviews (Print). 2001, Vol 19, Num 2, pp 97-115, issn 0897-5957Article

Myocardial salvage efficacy of the thromboxane receptor antagonist ifetroban in ferrets and dogsGOMOLL, A. W; GROVER, G. J; OGLETREE, M. L et al.Journal of cardiovascular pharmacology. 1994, Vol 24, Num 6, pp 960-968, issn 0160-2446Article

Effect of ifetroban, a thromboxane A₂ receptor antagonist, in stroke-prone spontaneously hypertensive ratsJOHNSON, R. A; BELMONTE, A; FAN, N. Y.-T et al.Clinical and experimental hypertension (1993). 1996, Vol 18, Num 2, pp 171-188, issn 1064-1963Article

Failure of aspirin to interfere with the cardioprotective effects of ifetrobanGOMOLL, A. W; OGLETREE, M. L.European journal of pharmacology. 1994, Vol 271, Num 2-3, pp 471-479, issn 0014-2999Article

In vitro model(s) for the percutaneous delivery of active tissue repair agentsWALKER, M; HULME, T. A; RIPPON, M. G et al.Journal of pharmaceutical sciences. 1997, Vol 86, Num 12, pp 1379-1384, issn 0022-3549Article